Aarey Drugs & Pharmaceuticals
AAREYDRUGS · Pharma > Pharmaceuticals & Drugs · Chairman: Mihir R Ghatalia · MD: Mihir R Ghatalia · Listing date: Aug. 7, 2021 · Mumbai · http://www.aareydrugs.com

Stock Price vs Company Growth
1d
4.8%
1w
3.6%
1m
5.0%
3m
-0.0%
6m
26.8%
1y
44.4%
all
4.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 48.7 4.8%
41.9
57
Company Overview

Sales
396 Cr
Growth: -8.4%
Profit after Tax
5.57 Cr
Growth: 47.4%
Micro Cap
137 Cr
P/E: 23.0x
Industry P/E: 36.7x
Fundamentals

Sales (Cr) ₹ 396
Growth -8.4%
EBITDA 1.1%
P/S 0.3x
Dividend 0.0%
P/E 23.0x
Book Value ₹ 24.9
PEG Ratio -2.7x
ROE 8.6%
P/B 1.9x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.The company also export its products to various other countries like Germany, Sri Lanka, Pakistan, Nepal and a number of African countries and is looking to establish its trade relations in other parts of the world as well.
Investors (2)